Chemotherapy and radiotherapy resistance are major obstacles in the long-term efficacy of head and neck squamous cell carcinoma (HNSCC) treatment. Secondhand smoke (SHS) exposure is common and has been proposed as an independent predictor of HNSCC recurrence and disease-free survival. However, the underlying mechanisms responsible for these negative patient outcomes are unknown. To assess the effects of SHS exposure on cisplatin efficacy in cancer cells, three distinct HNSCC cell lines were exposed to sidestream (SS) smoke, the main component of SHS, at concentrations mimicking the nicotine level seen in passive smokers’ saliva and treated with cisplatin (0.01–100 µM) for 48 h. Compared to cisplatin treatment alone, cancer cells exposed to both cisplatin and SS smoke extract showed significantly lower cisplatin-induced cell death and higher cell viability, IC50, and indefinite survival capacity. However, SS smoke extract exposure alone did not change cancer cell viability, cell death, or cell proliferation compared to unexposed control cancer cells. Mechanistically, exposure to SS smoke extract significantly reduced the expression of cisplatin influx transporter CTR1, and increased the expression of multidrug-resistant proteins ABCG2 and ATP7A. Our study is the first to document that exposure to SHS can increase cisplatin resistance by altering the expression of several proteins involved in multidrug resistance, thus increasing the cells’ capability to evade cisplatin-induced cell death. These findings emphasize the urgent need for clinicians to consider the potential role of SHS on treatment outcomes and to advise cancer patients and caregivers on the potential benefits of avoiding SHS exposure.
The present study aims to identify the association between androgen status and metabolic activity in skeletal and cardiac muscles of adult rats with transient gestational/neonatal-onset hypothyroidism. Pregnant and lactating rats were made hypothyroid by exposing to 0.05% methimazole in drinking water; gestational exposure was from embryonic day 9–14 (group II) or 21 (group III), lactational exposure was from postnatal day 1–14 (group IV) or 29 (group V). Serum was collected for hormone assay. Androgen receptor status, Glu-4 expression, and enzyme activities were assessed in the skeletal and cardiac muscles. Serum testosterone and estradiol levels decreased in adult rats of groups II and III, whereas testosterone remained normal but estradiol increased in group IV and V, when compared to coeval control. Androgen receptor ligand binding activity increased in both muscle phenotypes with a consistent increase in the expression level of its mRNA and protein expressions except in the forelimb of adult rats with transient hypothyroidism (group II–V). Glut-4 expression remained normal in skeletal and cardiac muscle of experimental rats. Specific activity of hexokinase and lactate dehydrogenase increased in both muscle phenotypes whereas, creatine kinase activity increased in skeletal muscles alone. It is concluded that transient gestational/lactational exposure to methimazole results in hypothyroidism during prepuberal life whereas it increases AR status and glycolytic activity in skeletal and cardiac muscles even at adulthood. Thus, the present study suggests that euthyroid status during prenatal and early postnatal life is essential to have optimal AR status and metabolic activity at adulthood.
5 September 2026 in Ecotoxicology and Environmental Safety
Colorectal cancer (CRC) is a leading cause of cancer-related mortality, driven by metastasis and drug resistance. Exosomes, nanosized extracellular vesicles, are promising candidates for CRC treatment. They facilitate intercellular communication, influencing tumour progression and the microenvironment. As natural carriers, exosomes transport proteins, lipids, and genetic material, making them ideal for drug delivery systems. They offer advantages over traditional methods, including penetration of biological barriers, minimal immunogenicity, and high biocompatibility. Exosomes deliver therapeutic agents like siRNAs, miRNAs, and chemotherapeutics directly to tumour cells, enhancing efficacy and minimizing off-target effects. Additionally, their potential as non-invasive biomarkers shows promise for early CRC detection. While current therapies often lead to adverse effects and resistance, exosomes selectively target cancer cells, sparing healthy tissue. Challenges with natural exosomes, such as scalability and stability, hinder clinical translation. Artificial exosomes address these limitations, enabling large-scale production and enhanced targeting capabilities. This chapter reviews exosomes as drug carriers in CRC, highlighting their potential to revolutionize treatment. It discusses advancements in artificial exosomes and strategies to overcome clinical challenges, emphasizing their promise in optimizing CRC therapy. <!----> <!----> <!----> <!---->
Microrobots, also known as microbots, represent a booming field at the intersection of robotics and medicine, offering precise manipulation at the microscopic level. In the context of colorectal cancer (CRC) research, microrobots hold immense promise for both diagnostic and therapeutic applications. This chapter provides an overview of microrobots, highlighting their potential in revolutionizing CRC treatment through targeted drug delivery, enhanced diagnostic procedures, and immunomodulation. Key topics discussed include the design considerations for microrobots in CRC applications, implications for CRC diagnosis and treatment, innovative drug delivery strategies, and immunomodulation approaches. Challenges such as biocompatibility, safety concerns, regulatory hurdles, and ethical considerations are also addressed. By exploring advancements in microrobot technology and interdisciplinary collaborations, this chapter elucidates the potential of microrobots to transform CRC research and treatment, offering new avenues for improving patient outcomes. <!----> <!----> <!----> <!---->